Edition:
United States

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

940.50INR
12:04am EDT
Change (% chg)

Rs0.20 (+0.02%)
Prev Close
Rs940.30
Open
Rs940.55
Day's High
Rs940.55
Day's Low
Rs936.05
Volume
1,096
Avg. Vol
9,244
52-wk High
Rs1,234.90
52-wk Low
Rs908.00

Latest Key Developments (Source: Significant Developments)

Pfizer enters into delegation of authority with Astrazeneca Pharma India
Wednesday, 18 Jan 2017 07:49am EST 

Pfizer Ltd : Pfizer Ltd says entered into delegation of authority with Astrazeneca Pharma India . Pfizer Ltd says Meronem IV injection, currently marketed in India by Astrazeneca, is expected to be transitioned to co .Pfizer Ltd - co granted authority for pricing and reimbursement talks, promotional, marketing, tendering and bidding for injectable antibiotic products.  Full Article

Astrazeneca Pharma India March-qtr profit falls
Wednesday, 25 May 2016 06:06am EDT 

Astrazeneca Pharma India Ltd : Says March-quarter net profit 5.6 million rupees; March-quarter net sales 1.34 billion rupees .  Full Article

Astrazeneca Pharma India Ltd launches FORXIGA - a treatment of Type 2 diabetes in India
Thursday, 11 Jun 2015 12:08am EDT 

Astrazeneca Pharma India Ltd:Launches FORXIGA, a treatment for Type 2 diabetes mellitus.Says FORXIGA belongs to a new class of type 2 diabetes mellitus medication - an inhibitor of sodium-glucose cotransporter 2.Says it has a insulin independent mode of action that helps remove excess glucose from the body via urine which is associated with reductions in glycated haemoglobin, weight and systolic blood pressure.  Full Article

Astrazeneca Pharma India Ltd and Sun Pharmaceutical Industries Ltd enter into distribution agreement for ticagrelor in India
Wednesday, 3 Jun 2015 09:11am EDT 

Astrazeneca Pharma India Ltd:Entered into a distribution services agreement for AstraZeneca’s brand Axcer, a new brand of ticagrelor, a drug used for the treatment of acute coronary syndrome (ACS) in India.AZPIL already has a brand under the trademark Brilinta, for the ticagrelormolecule, launched and marketed by AZPILin India since 2012.  Full Article

More From Around the Web

BRIEF-Pfizer enters into delegation of authority with Astrazeneca Pharma India

* Pfizer Ltd says entered into delegation of authority with Astrazeneca Pharma India

No consensus analysis data available.